Clinical trials
Cancer Diagnosis clinical trials
Below are recruiting cancer diagnosis clinical trials, each written for real people, not researchers. We’re tracking 254 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07059923Recruiting
Predicting immunotherapy response in lung cancer with AI and radiology
This study uses artificial intelligence and CT scan analysis to predict how well lung cancer patients will respond to immunotherapy. It may help doctors choose the best treatment for you.
Wuhan, HubeiAges 18 years+ - NCT07384897Recruiting
Immune cells in lung cancer and chronic lung disease
This study looks at how immune cells work in lung cancer and chronic lung diseases. It aims to find better ways to treat these conditions by studying immune cells from blood, bone marrow, or lung samples.
BrusselsAges Up to 80 years - NCT05561842Recruiting
Mobile ultrasound tablet test for breast cancer diagnosis in Nigeria
This study tests a tablet-based ultrasound (a scan using sound waves) to help identify breast lumps that look like cancer. If your lump looks suspicious, the scan result is intended to guide next steps like biopsy or surgical removal at the hospital.
New York, New YorkAges 18 years+ - NCT06420115Recruiting
Comparing needle sizes for prostate MRI-targeted biopsy
This study compares two different needle sizes used during a prostate biopsy to see which one finds cancer more accurately and causes fewer side effects. It is for people who have not been diagnosed with prostate cancer before and have a suspicious MRI finding.
Padua, ItalyAges 18 years+ - NCT07651644Recruiting
AI tool to help doctors read gastric cancer imaging
This study tests whether an AI-assisted tool helps radiologists (doctors who read imaging scans) better interpret CT scans of gastric cancer patients. The research compares how accurately doctors read scans with and without AI help.
Shenyang, LiaoningAges Any age - NCT07538947Recruiting
Real-time imaging to diagnose lung cancer faster and safer
This trial tests a new camera tool (confocal laser endomicroscopy) that lets doctors see lung tissue in real-time during a biopsy procedure. The goal is to diagnose non-small cell lung cancer more quickly and safely than standard biopsies alone.
NancyAges 18 years+ - NCT07211529Recruiting
Nerve block during chest surgery to reduce complications
This trial tests whether a numbing injection near the spine (paravertebral block) given during keyhole chest surgery can lower the risk of problems after surgery. It might help patients recover more comfortably.
Wuhan, HubeiAges 18–80 - NCT07168993Recruiting
Testing a new sputum test for lung cancer in high-risk adults
This study tests a new, non-invasive sputum test (FlowPath Lung) to see if it can accurately detect lung cancer in people at high risk who have a lung nodule. If you are between 50 and 80, have a smoking history, and have a lung nodule, this test may help decide if further steps are needed.
Palo Alto, CaliforniaAges 50–80 - NCT07047573Recruiting
Better testing for lung nodules to tell benign from cancer
This study uses advanced testing methods on lung nodules to better tell if they are benign (not cancer) or malignant (cancer). It may help improve diagnosis for people scheduled for surgery to remove a lung nodule.
Suzhou, JiangsuAges Any age - NCT06659705RecruitingPhase 2
New PET scan for early pancreatic cancer detection
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
Saint-CloudAges 18 years+ - NCT07416513Recruiting
Digital tools for better cancer care
This study explores how digital tools (apps or websites) can help people affected by cancer, including patients, caregivers, and healthcare workers. If you are a current or past cancer patient, a caregiver, or an oncology professional, you may be able to join.
CaenAges 12 years+ - NCT06336928Recruiting
Blood test validation for breast cancer diagnosis
This study is testing a new blood test (liquid biopsy) to see if it can accurately detect breast cancer or track remission. If you are a woman getting a mammogram, have an abnormal finding, were recently diagnosed, or are in remission after treatment, you may be able to join and help validate this test.
Los Angeles, CaliforniaAges 18 years+ - NCT07567027Recruiting
Testing a spacing gel to improve prostate cancer freezing treatment
This trial tests whether a special gel placed between the prostate and rectum improves the safety and effectiveness of cryoablation—a freezing treatment for prostate cancer. The gel aims to protect the rectum from cold damage during the procedure.
New York, New YorkAges 40–95 - NCT06535802Recruiting
Prostate cancer support for Black men in Florida
This study tests a new program to help Black men recently diagnosed with prostate cancer. It aims to provide support right after diagnosis to improve care and well-being.
Jacksonville, FloridaAges Up to 80 years - NCT06645691RecruitingPhase 2
Heart and metabolic imaging study using a special MRI scan
This study tests a new MRI method that uses a safe, natural substance (pyruvate) to take detailed pictures of the heart and metabolism. It may help doctors better understand heart disease, diabetes, and related conditions.
SingaporeAges 21–99 - NCT06791473Recruiting
AI cancer diagnosis study using electronic health records
This study uses artificial intelligence to analyze electronic health records (including medical history, lab results, and imaging data) to improve cancer diagnosis and prediction. It aims to help identify cancer earlier and more accurately, potentially leading to better treatment outcomes.
Guangzhou, GuangdongAges birth–90 years - NCT07069556Recruiting
ColoSense stool test study before colonoscopy
This study is testing a new stool-based screening test for colorectal cancer. You provide a stool sample before having a colonoscopy, and researchers compare the test results with what the colonoscopy finds.
St Louis, MissouriAges 18 years+ - NCT07271017RecruitingPhase 1
Robot-assisted prostate biopsy using a new ultrasound probe
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
Baltimore, MarylandAges 40–75 - NCT07310537Recruiting
Liquid biopsy trial for colorectal cancer liver metastases
This study tests whether a simple blood sample from your finger can detect tumor DNA as well as a standard blood draw. It is designed for people with colorectal cancer that has spread to the liver and hasn't responded to treatment.
Rotterdam, South HollandAges 21 years+ - NCT07369570Recruiting
Watching low-risk prostate lesions with repeat MRI scans
This trial uses repeated MRI scans to monitor prostate lesions that have a low chance of being aggressive cancer. It is for people who have suspicious spots but whose initial biopsies did not find high-grade cancer.
KuopioAges 40 years+ - NCT07399210Recruiting
Detecting lung nodule cancer with a blood test
This study aims to see if a blood test can tell if a lung nodule is cancerous or not. It may help doctors avoid unnecessary procedures.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07418450Recruiting
Comparing two needle methods for lung cancer staging
This trial compares two ways of collecting tissue samples from lymph nodes in the chest during a procedure called EBUS-TBNA. The goal is to see if changing the needle during the procedure gives better results for diagnosing lung cancer.
ViennaAges 18 years+ - NCT07477522RecruitingPhase 1
High-fiber diet study for solid tumor patients
This trial tests whether eating a high-fiber diet can improve your gut health, metabolism, and immune system. It is for people with solid tumors who are able to eat or use a feeding tube.
Chengdu, SichuanAges 18–75 - NCT07591389Recruiting
Radon Testing Education for Mothers of Young Children
This study tests ways to encourage mothers to test their homes for radon, a colorless gas that can build up indoors and pose health risks. Researchers want to learn how to help families protect their young children's health.
Bismarck, North DakotaAges 18 years+
Hear when a new Cancer Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer diagnosis?
- Yes. Clin2 currently lists 254 recruiting cancer diagnosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer diagnosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer diagnosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.